Encodia
Encodia is a biotechnology company focused on revolutionizing proteomics research through its innovative ProteoCode™ technology. Their mission is to solve challenging scientific problems by enabling scalable, in-depth protein analysis that accelerates discoveries in human health and personalized medicine.
Industries
biotechnology
chemical
Nr. of Employees
medium (51-250)
Patents
Products
Sequencing‑enabled protein analysis platform (reverse translation to DNA libraries)
A platform that converts peptide sequence information into DNA library elements and uses DNA barcodes and NGS readout to enable high‑throughput proteomic analysis.
Sequencing‑enabled protein analysis platform (reverse translation to DNA libraries)
A platform that converts peptide sequence information into DNA library elements and uses DNA barcodes and NGS readout to enable high‑throughput proteomic analysis.
Services
Point of contact for technology inquiries, collaborations, and requests for information about sequencing‑based proteomics approaches.
Point of contact for technology inquiries, collaborations, and requests for information about sequencing‑based proteomics approaches.
Expertise Areas
- Proteomics
- Sequencing‑based assay development
- Next‑generation sequencing applications
- High‑throughput proteomic workflows
Key Technologies
- Next‑generation sequencing (NGS)
- DNA barcoding for amino acids
- Peptide–DNA chimera construction
- Affinity reagent–based detection with DNA tags